ENOV — Enovis CORP
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1420800 ·
Last close
$18.46
Market Cap
$1.06B
52W High
$34.28
52W Low
$17.30
ADV30
1,668,757
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 589,151,000 | 365,485,000 | 9,238,000 | -8,764,000 | 3,832,256,000 | 33,129,000 | 2,352,764,000 |
| Dec 2025 | 575,758,000 | 349,421,000 | 48,254,000 | -520,589,000 | 3,834,737,000 | 36,389,000 | 2,342,835,000 |
| Sep 2025 | 548,912,000 | 328,913,000 | -8,136,000 | -571,146,000 | 4,433,367,000 | 33,617,000 | 2,409,689,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$242,840,000
Investing CF
$-171,947,000
Financing CF
$-77,568,000
CapEx
$-206,918,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-19.26
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,476,227,000
Inventory
$602,543,000
Receivables
$444,206,000
ST Investments
—
EBIT TTM
$-1,066,631,000
Pretax Income TTM
$-1,101,435,000
Interest Exp TTM
$34,804,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,296,602,880
EBITDA
$379,779,008
Free Cash Flow
$185,942,752
Enterprise Value
$2,470,450,944
Total Cash
$12,563,000
Total Debt
$1,369,048,064
Shares Out
57,669,494
Trailing EPS
$-19.27
Book Value
$25.61
ROE
-54.1%
ROA
1.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,248,049,000 | -18,869,000 | -1,184,440,000 | 3,834,737,000 | 2,342,835,000 | 1,489,645,000 | 217,293,000 |
| Dec 2024 | 2,107,623,000 | -103,429,000 | -825,494,000 | 4,718,777,000 | 2,154,448,000 | 2,562,262,000 | 113,504,000 |
| Dec 2023 | 1,707,197,000 | -48,374,000 | -33,261,000 | 4,509,334,000 | 1,088,633,000 | 3,418,392,000 | 134,988,000 |
| Dec 2022 | 1,563,101,000 | -90,658,000 | -13,292,000 | 4,273,248,000 | 823,447,000 | 3,448,085,000 | -55,861,000 |
TTM Snapshot
Revenues TTM
$1,865,394,000
NetIncome TTM
$-156,979,000
OpCashFlow TTM
$0
Assets (Latest)
$3,834,737,000
Forward EPS
$3.69
Max Pain — expiry 2026-10-16
max pain strike: $22.50 · spot: $18.21 · call oi: 3,701 · put oi: 1,059
Expected Move to 2026-10-16:
±$2.60
(14.28%) —
implied range
$15.61 –
$20.81
· ATM straddle on $17.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| STVN | Stevanato Group S.p.A. | $1.05B | $21.13 | — |
| TNDM | TANDEM DIABETES CARE INC | $1.09B | $15.72 | — |
| IRMD | IRADIMED CORP | $1.10B | $85.76 | — |
| AORT | ARTIVION, INC. | $1.10B | $22.63 | — |
| CDRE | Cadre Holdings, Inc. | $1.13B | $26.39 | — |
News headlines (Yahoo Finance, 1h cache)
Sports Rehabilitation Equipment Market Global Report 2026: Capitalize on a $2.05 Billion Revenue Surge to $6.84 Billion by 2030 as AI and Robotics Disrupt Recovery—Benchmark Stryker, Smith & Nephew, E
2026-09-28 09:16 · Yahoo
3 Reasons ENOV is Risky and 1 Stock to Buy Instead
2026-09-17 18:42 · Yahoo
Insider at Medical Device Maker Buys More Than 7,500 Shares
2026-09-14 14:15 · Yahoo
Q2 Earnings Highlights: Enovis (NYSE:ENOV) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
2026-09-04 16:46 · Yahoo
What Makes Enovis (ENOV) a New Buy Stock
2026-09-03 16:00 · Yahoo
Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
2026-09-03 13:35 · Yahoo
Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition
2026-09-02 17:33 · Yahoo
Enovis inks eCential takeover to develop surgical ortho robots
2026-09-02 10:00 · Yahoo
Enovis Targets Robotic Surgery Expansion With €155M eCential Robotics Deal
2026-09-01 14:03 · Yahoo
eCential Robotics Announces Binding Offer from Enovis
2026-09-01 10:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.